StockData
Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc. (AVIR) stock

AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$3.99+0.03 (+0.76%)

Close on Nov 18, 2026Market cap $320.02MP/E –Yield –

Atea Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Atea Pharmaceuticals's market cap was $338.46M on Nov 11, 2026, against $242.19M a year earlier. Over the last 5 years it ranged from $235.30M to $742.44M, with a median of $325.02M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$338.46M+21.4%
2025Dec 31, 2025$278.91M-1.4%
2024Dec 31, 2024$282.95M+11.2%
2023Dec 29, 2023$254.48M-36.5%
2022Dec 30, 2022$400.61M-46.0%
2021Dec 31, 2021$742.44M+75.8%
2020Dec 31, 2020$422.39M–

More Atea Pharmaceuticals figures

See a number that looks wrong?